D
Amylyx Pharmaceuticals, Inc. AMLX
$3.63 -$0.045-1.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -37.55M -72.70M -72.70M -118.79M 4.73M
Total Depreciation and Amortization 160.00K 221.00K 208.00K 315.00K 301.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 5.08M 41.51M 14.61M 117.83M 6.96M
Change in Net Operating Assets -26.70M -10.60M -8.70M 164.00K 1.56M
Cash from Operations -59.01M -41.57M -66.58M -489.00K 13.55M
Capital Expenditure -20.00K -36.18M -89.00K -67.00K -356.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 65.00M 75.00M -28.87M 886.00K 21.28M
Cash from Investing 64.98M 38.82M -28.96M 819.00K 20.93M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 148.00K 491.00K 47.00K 1.45M 347.00K
Repurchase of Common Stock -38.00K -411.00K -20.00K -1.32M -117.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 0.00
Cash from Financing 110.00K 80.00K 27.00K 131.00K 230.00K
Foreign Exchange rate Adjustments -525.00K 236.00K -39.00K -110.00K 237.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 5.56M -2.44M -95.55M 351.00K 34.94M
Weiss Ratings